FGF-20 Antibodies

Santa Cruz Biotechnology delivers a wide array of FGF-20 monoclonal antibodies for research focused on understanding Fibroblast Growth Factor 20. FGF-20 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FGF-20 is a member of the fibroblast growth factor family, which plays a crucial role in cell proliferation, differentiation, and survival. FGF-20 demonstrates significant involvement in the development of the nervous system and has been implicated in neurogenesis and the maintenance of neuronal health. Research has shown that FGF-20 signaling pathways influence various biological processes related to neural development and function. Understanding FGF-20 mechanisms can reveal potential therapeutic targets for neurological disorders. Investigating FGF-20 expression patterns helps researchers uncover its role in both normal development and disease states. Current studies indicate that FGF-20 may have therapeutic applications in treating neurodegenerative conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of FGF-20's role in human health and disease.